Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants

Science of the Total Environment

Volumn 442, Issue , 2013, Pages 310-316

  Yu, Yong ^a   Wu, Laosheng ^a   Chang, Andrew C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EDCs; PPCPs; Seasonal variation; WWTPs

Indexed keywords

CARBAMAZEPINE; ECOLOGICAL RISKS; ECOTOXICOLOGICAL RISKS; EDCS; ENDOCRINE DISRUPTING COMPOUND; ENVIRONMENTAL CONCENTRATION; HUMAN CONSUMPTION; MEAN CONCENTRATIONS; NAPROXENS; OCTYLPHENOLS; PARACETAMOL; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PPCPS; PREDICTED NO-EFFECT CONCENTRATIONS; REMOVAL EFFICIENCIES; SEASONAL VARIATION; SLUDGE SAMPLES; SOUTHERN CALIFORNIA; TRICLOSAN; WASTEWATER TREATMENT PLANTS; WWTPS;

AMIDES; DRUG PRODUCTS; HEALTH RISKS; SEWAGE PUMPING PLANTS; SEWAGE SLUDGE; WATER TREATMENT PLANTS;

EFFLUENTS;

4 N NONYLPHENOL; 4 TERT OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ACETYLSALICYLIC ACID; CARBAMAZEPINE; CLOFIBRIC ACID; COSMETIC; DICLOFENAC; DRUG; ENDOCRINE DISRUPTOR; ESTRONE; GEMFIBROZIL; IBUPROFEN; KETOPROFEN; NAPROXEN; OCTYLPHENOL; PARACETAMOL; TRICLOSAN; UNCLASSIFIED DRUG; 4 NONYLPHENOL;

ENDOCRINE DISRUPTOR; SEASONAL VARIATION; WASTE TREATMENT; WASTEWATER; WATER TREATMENT; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; ENVIRONMENTAL RISK; POLLUTANT REMOVAL; SLUDGE;

ARTICLE; BIODEGRADATION; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); ECOTOXICITY; EFFLUENT; ENVIRONMENTAL PARAMETERS; INFLUENT; PHYSICAL CHEMISTRY; PREDICTED NO EFFECT CONCENTRATION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; RISK QUOTIENT; SEASONAL VARIATION; SLUDGE; SUMMER; UNITED STATES; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER POLLUTANT; WINTER; CHEMISTRY; SEASON; WASTE WATER; WATER MANAGEMENT; BIOREMEDIATION; ECOTOXICOLOGY; HAZARD ASSESSMENT; HEALTH HAZARD; SEWAGE EFFLUENT; SLUDGE TREATMENT; WATER ANALYSIS;

CALIFORNIA; UNITED STATES;

CALIFORNIA; COSMETICS; ENDOCRINE DISRUPTORS; PHARMACEUTICAL PREPARATIONS; SEASONS; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84869886405     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.10.001     Document Type: Article

References (41)

1. Abdelmelek S.B., Greaves J., Ishida K.P., Cooper W.J., Song W.H. Removal of pharmaceutical and personal care products from reverse osmosis retentate using advanced oxidation processes. Environ Sci Technol 2011, 45:3665-3671.
2. Basile T., Petrella A., Petrella M., Boghetich G., Petruzzelli V., Colasuonno S., et al. Review of endocrine-disrupting-compound removal technologies in water and wastewater treatment plants: an EU perspective. Ind Eng Chem Res 2011, 50:8389-8401.
3. Boleda M.R., Galceran M.T., Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ Pollut 2011, 159:1584-1591.
4. Boxall A.B.A., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
5. Brausch J.M., Rand G.M. A review of personal care products in the aquatic environment: environmental concentrations and toxicity. Chemosphere 2011, 82:1518-1532.
6. Brausch J.M., Connors K.A., Brooks B.W., Rand G.M. Human pharmaceuticals in the aquatic environment: a critical review of recent toxicological studies and considerations for toxicity testing. Rev Environ Contam Toxicol 2012, 218:1-99.
7. Calderón-Preciado D., Jiménez-Cartagena C., Matamoros V., Bayona J.M. Screening of 47 organic microcontaminants in agricultural irrigation waters and their soil loading. Water Res 2011, 45:221-231.
8. Capdevielle M., Van Egmond R., Whelan M., Versteeg D., Hofmann-Kamensky M., Inauen J., et al. Consideration of exposure and species sensitivity of triclosan in the freshwater environment. Integr Environ Assess Manag 2008, 4:15-23.
9. EPA 832-R-06-005 Emerging technologies for biosolids management 2006, [September], Office of Wastewater Management, US Environmental Protection Agency, Washington, DC.
10. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011, 45:75-92.
11. EU Ad Hoc Working Party, III/5504/94 Draft 4 Assessment of potential risks to the environment posed by medicinal products for human use, excluding products containing live genetically modified organisms 1994, [EU].
12. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003, 55:359-370.
13. Ferrari B., Mons R., Vollat B., Fraysse B., Paxéus N., Lo Giudice R., et al. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ Toxicol Chem 2004, 23:1344-1354.
14. Flippin J.L., Huggett D., Foran C.M. Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes). Aquat Toxicol 2007, 81:73-83.
15. Herklotz P.A., Gurung P., Heuvel B.V., Kinney C.A. Uptake of human pharmaceuticals by plants grown under hydroponic conditions. Chemosphere 2010, 78:1416-1421.
16. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 2011, 45:1165-1176.
17. Karickhoff S.W. Semi-empirical estimation of sorption of hydrophobic pollutants on natural sediments and soils. Chemosphere 1981, 10:833-846.
18. Kleywegt S., Pileggi V., Yang P., Hao C.Y., Zhao X.M., Rocks C., et al. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada - occurrence and treatment efficiency. Sci Total Environ 2011, 409:1481-1488.
19. Lavén M., Alsberg T., Yu Y., Adolfsson-Erici M., Sun H.W. Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J Chromatogr A 2009, 1216:49-62.
20. Lin A.Y.C., Yu T.H., Lin C.F. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 2008, 74:131-141.
21. Loraine G.A., Pettigrove M.E. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol 2006, 40:687-695.
22. Luo Y., Xu L., Rysz M., Wang Y.Q., Zhang H., Alvarez P.J.J. Occurrence and transport of tetracycline, sulfonamide, quinolone and macrolide antibiotics in the Haihe River Basin, China. Environ Sci Technol 2011, 45:1827-1833.
23. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived US biosolids from the 2001 EPA national sewage sludge survey. Water Res 2010, 44:658-668.
24. Motoyama M., Nakagawa S., Tanoue R., Sato Y., Nomiyama K., Shinohara R. Residues of pharmaceuticals products in recycled organic manure produced from sewage sludge and solid waste from livestock and relationship to their fermentation level. Chemosphere 2011, 84:432-438.
25. Nelson E.D., Do H., Lewis R.S., Carr S.A. Diurnal variability of pharmaceutical, personal care product, estrogen and alkylphenol concentrations in effluent from a tertiary wastewater treatment facility. Environ Sci Technol 2011, 45:1228-1234.
26. Ockene I.S., Chiriboga D.E., Stanek I.I.I.E.J., Harmatz M.G., Nicolosi R., Saperia G., et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 2004, 164:863-870.
27. Phillips P.J., Smith S.G., Kolpin D.W., Zaugg S.D., Buxton H.T., Furlong E.T., et al. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol 2010, 44:4910-4916.
28. Prasse C., Schlusener M.P., Schulz R., Ternes T.A. Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance?. Environ Sci Technol 2010, 44:1728-1735.
29. Quinn B., Gagné F., Blaise C. The effects of pharmaceuticals on the regeneration of the cnidarian, Hydra attenuata. Sci Total Environ 2008, 402:62-69.
30. Reungoat J., Escher B.I., Macova M., Keller J. Biofiltration of wastewater treatment plant effluent: effective removal of pharmaceuticals and personal care products and reduction of toxicity. Water Res 2011, 45:2751-2762.
31. Rosal R., Rodríguez A., Perdigón-Melón J.A., Petre A., García-Calvo E., Gómez M.J., et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 2010, 44:578-588.
32. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lützhøft H.C., Halling-Sørensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
33. Sui Q., Huang J., Deng S.B., Chen W.W., Yu G. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ Sci Technol 2011, 45:3341-3348.
34. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39:1761-1772.
35. Triebskorn R., Casper H., Heyda A., Eikemper R., Kohler H.-R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills, and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2004, 68:176-183.
36. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39:8220-8226.
37. Wu M., Janssen S. Dosed without prescription: a framework for preventing pharmaceutical contamination of our nation's drinking water. Environ Sci Technol 2011, 45:366-367.
38. Wu C.X., Spongberg A.L., Witter J.D., Fang M., Czajkowski K.P. Uptake of pharmaceutical and personal care products by soybean plants from soils applied with biosolids and irrigated with contaminated water. Environ Sci Technol 2010, 44:6157-6161.
39. Xu Y.L., Luo F., Pal A., Gin K.Y.H., Reinhard M. Occurrence of emerging organic contaminants in a tropical urban catchment in Singapore. Chemosphere 2011, 83:963-969.
40. Yu Y., Wu L.S. Comparison of four extraction methods for the analysis of pharmaceuticals in wastewater. J Chromatogr A 2011, 1218:2483-2489.
41. Yu Y., Wu L.S. Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography-mass spectrometry. Talanta 2012, 89:258-263.